Senior insider sale
SVP, Diagnostics, clonoSEQ at ADAPTIVE BIOTECHNOLOGIES CORP — senior position signals high conviction
$283.4K
16K shares
What this filing means
BOBULSKY SUSAN plans to sell 16K shares of ADAPTIVE BIOTECHNOLOGIES CORP valued at approximately $283.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/11/2026ACC: 0001950047-26-005958
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
16K
Shares to sell
$283.4K
Approx. market value
5K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Previously Exercised Stock Options
Cash
1/25/2022
5KTotal acquired5K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/25/2022 | Previously Exercised Stock Options Cash | 5K | — |
| Total | 5K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
11K
Market value
$198.0K
6/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5K
Market value
$85.3K
6/11/2026
Total
Units
16K
Value
$283.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/4/2026 | 11K | $198.0K | — | Completed |
| Planned — Approximate Date | ||||
6/11/2026 | 5K | $85.3K | NASDAQ | Planned |
| Total | 16K | $283.4K | ||